RA CAPITAL MANAGEMENT, LLC Insider Trading
Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is 10% Owner in LIPID SCIENCES INC/ ($LIPD) and 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and Director in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Verastem, Inc. ($VSTM) and 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in G1 Therapeutics, Inc. ($GTHX) and 10% Owner in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Wave Life Sciences Ltd. ($WVE) and 10% Owner in Vaxcyte, Inc. ($PCVX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in ARVINAS INC. ($ARVN) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in IMARA Inc. ($IMRA) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in Orchard Therapeutics plc ($ORTX) and Director in Orchard Therapeutics plc ($ORTX) and Director in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and Director in Nkarta, Inc. ($NKTX) and 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and Director in 89bio, Inc. ($ETNB) and 10% Owner in Pandion Therapeutics, Inc. ($PAND) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Vor Biopharma Inc. ($VOR) and 10% Owner in Dyne Therapeutics, Inc. ($DYN). Discover the current value of RA CAPITAL MANAGEMENT, LLC shares.
Address: 111 HUNTINGTON AVENUE, SUITE 610 BOSTON 02199MA
RA CAPITAL MANAGEMENT, LLC is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
LIPD | LIPID SCIENCES INC/ | 10% Owner | 3,713,962 | 0.00 |
ACRS | Aclaris Therapeutics, Inc. | 10% Owner | 2,607,719 | 65,844,904.75 |
WVE | Wave Life Sciences Ltd. | Director | 201,594 | 5,815,986.90 |
RARX | Ra Pharmaceuticals, Inc. | Director | 0 | 0.00 |
KALV | KalVista Pharmaceuticals, Inc. | Director | 1,441,070 | 979,927.60 |
DRNA | Dicerna Pharmaceuticals Inc | 10% Owner, Director | 5,074,013 | 13,090,953.54 |
GTHX | G1 Therapeutics, Inc. | 1,723,304 | ||
KALA | Kala Pharmaceuticals, Inc. | Director | 10,874,613 | |
EIDX | Eidos Therapeutics, Inc. | Director | 1,103,847 | |
ARVN | ARVINAS, INC. | 1,847,002 | ||
THOR | Synthorx, Inc. | 10% Owner | 0 | |
SCPH | scPharmaceuticals Inc. | 10% Owner | 3,247,005 | |
STSA | Satsuma Pharmaceuticals, Inc. | Director | 566,011 | |
ETNB | 89bio, Inc. | Director | 4,736,214 | |
PAND | Pandion Therapeutics, Inc. | 10% Owner | 1,408,912 | |
IMRA | IMARA Inc. | 10% Owner | 829,348 | |
PHAT | Phathom Pharmaceuticals, Inc. | 10% Owner | 3,115,008 | |
FMTX | Forma Therapeutics Holdings, Inc. | 10% Owner | 5,011,651 | |
VSTM | Verastem, Inc. | 10% Owner | 16,142,051 | 20,016,143.24 |
RYTM | RHYTHM PHARMACEUTICALS, INC. | 10% Owner | 5,210,088 | |
NKTX | Nkarta, Inc. | Director, 10% Owner | 260,819 | |
INZY | Inozyme Pharma, Inc. | 10% Owner | 1,403,653 | |
ITOS | iTeos Therapeutics, Inc. | Director, 10% Owner | 289,843 | |
INBX | Inhibrx, Inc. | 10% Owner | 2,129,003 | |
TGTX | TG THERAPEUTICS, INC. | 10% Owner | 12,629,868 | 61,254,859.80 |
DYN | Dyne Therapeutics, Inc. | 10% Owner | 2,145,045 | |
PMVP | PMV Pharmaceuticals, Inc. | 10% Owner | 760,265 | |
PCVX | Vaxcyte, Inc. | 10% Owner | 5,169,254 | |
ORTX | Orchard Therapeutics plc | Director, 10% Owner | 9,126,418 | |
ITRM | Iterum Therapeutics plc | 10% Owner | 11,651,597 | |
VOR | Vor Biopharma Inc. | Director | 755,726 | |
SLDB | Solid Biosciences Inc. | Director | 787,586 | |
HOWL | Werewolf Therapeutics, Inc. | Director | 1,915,546 |
Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
May 06 2021 | HOWL | Werewolf Therapeutics, In ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 1,915,546 | 0 | 1,915,546 |
May 06 2021 | HOWL | Werewolf Therapeutics, In ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 16.00 | 1,609,212 | 25,747,392 | 3,524,758 |
May 06 2021 | HOWL | Werewolf Therapeutics, In ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 338,037 | 0 | 338,037 |
May 06 2021 | HOWL | Werewolf Therapeutics, In ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 16.00 | 105,788 | 1,692,608 | 443,825 |
May 06 2021 | HOWL | Werewolf Therapeutics, In ... | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 16,606,068 | 0 | 0 |
May 06 2021 | HOWL | Werewolf Therapeutics, In ... | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 2,930,482 | 0 | 0 |
Apr 05 2021 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 32.90 | 260,819 | 8,580,945 | 260,819 |
Apr 05 2021 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 32.90 | 307,214 | 10,107,341 | 4,589,999 |
Apr 05 2021 | ITOS | iTeos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 34.18 | 289,843 | 9,906,834 | 289,843 |
Apr 05 2021 | ITOS | iTeos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 34.18 | 131,364 | 4,490,022 | 3,155,667 |
Apr 05 2021 | SLDB | Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 5.53 | 787,586 | 4,355,351 | 787,586 |
Apr 05 2021 | SLDB | Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 5.53 | 663,720 | 3,670,372 | 11,580,287 |
Apr 05 2021 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 5.61 | 201,594 | 1,130,942 | 201,594 |
Apr 05 2021 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 5.61 | 768,431 | 4,310,898 | 7,573,613 |
Apr 05 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 43.10 | 755,726 | 32,571,791 | 755,726 |
Apr 05 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 43.10 | 242,656 | 10,458,474 | 8,539,921 |
Apr 05 2021 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 5.91 | 566,011 | 3,345,125 | 566,011 |
Apr 05 2021 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 5.91 | 192,387 | 1,137,007 | 5,348,241 |
Mar 15 2021 | PHAT | Phathom Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 43.75 | 710,000 | 31,062,500 | 3,115,008 |
Feb 11 2021 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 3,215,434 | 0 | 3,215,434 |
Feb 11 2021 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 3,215,434 | 0 | 3,215,434 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 1,664,549 | 0 | 1,664,549 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 280,330 | 0 | 280,330 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 3,784,120 | 0 | 5,448,669 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 1,414,026 | 0 | 1,694,356 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 18.00 | 2,848,596 | 51,274,728 | 8,297,265 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 18.00 | 130,970 | 2,357,460 | 1,825,326 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 22,637,875 | 0 | 0 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 3,812,500 | 0 | 0 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 51,464,036 | 0 | 0 |
Feb 09 2021 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 19,230,770 | 0 | 0 |
Feb 08 2021 | ITRM | Iterum Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 11,651,597 | 0 | 11,651,597 |
Feb 08 2021 | ITRM | Iterum Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 8,486,000 | 0 | 0 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.75 | 14,570 | 69,208 | 9,126,418 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.71 | 6,787 | 31,967 | 9,133,205 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.74 | 16,291 | 77,219 | 9,149,496 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.74 | 13,031 | 61,767 | 9,162,527 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.74 | 8,235 | 39,034 | 9,170,762 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.72 | 45,249 | 213,575 | 9,216,011 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.69 | 55,204 | 258,907 | 9,271,215 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.65 | 9,050 | 42,083 | 9,280,265 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.61 | 58,106 | 267,869 | 9,338,371 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.61 | 4,525 | 20,860 | 9,342,896 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.64 | 54,416 | 252,490 | 9,397,312 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.51 | 10,226 | 46,119 | 9,407,538 |
Nov 06 2020 | ORTX | Orchard Therapeutics plc | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 4.61 | 473,327 | 2,182,037 | 9,880,865 |
Oct 09 2020 | PCVX | Vaxcyte, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 50.95 | 98,597 | 5,023,527 | 5,169,254 |
Oct 09 2020 | PCVX | Vaxcyte, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 50.69 | 167,661 | 8,498,065 | 5,001,593 |
Oct 01 2020 | PCVX | Vaxcyte, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 52.08 | 80,707 | 4,202,987 | 5,408,474 |
Oct 01 2020 | PCVX | Vaxcyte, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 50.27 | 124,656 | 6,265,871 | 5,283,818 |
Oct 01 2020 | PCVX | Vaxcyte, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 48.64 | 15,967 | 776,705 | 0 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 760,265 | 0 | 760,265 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 18.00 | 950,000 | 17,100,000 | 1,710,265 |
Sep 29 2020 | PMVP | PMV Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 760,265 | 0 | 0 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 2,145,045 | 0 | 2,145,045 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 19.00 | 660,000 | 12,540,000 | 2,805,045 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 7,114,905 | 0 | 0 |
Sep 21 2020 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 28.00 | 1,300,000 | 36,400,000 | 4,736,214 |
Sep 11 2020 | TGTX | TG THERAPEUTICS, INC. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 25.81 | 158,589 | 4,092,738 | 12,629,868 |
Aug 24 2020 | INBX | Inhibrx, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 2,129,003 | 0 | 2,129,003 |
Aug 24 2020 | INBX | Inhibrx, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 3,700,634 | 0 | 0 |
Jul 29 2020 | ITOS | iTeos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 2,992,259 | 0 | 2,992,259 |
Jul 29 2020 | ITOS | iTeos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 19.00 | 1,425,000 | 27,075,000 | 4,417,259 |
Jul 29 2020 | ITOS | iTeos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 9,751,773 | 0 | 0 |
Jul 28 2020 | INZY | Inozyme Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 1,403,653 | 0 | 1,403,653 |
Jul 28 2020 | INZY | Inozyme Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 16.00 | 600,000 | 9,600,000 | 2,003,653 |
Jul 28 2020 | INZY | Inozyme Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 10,489,510 | 0 | 0 |
Jul 22 2020 | PAND | Pandion Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 1,408,912 | 0 | 1,408,912 |
Jul 22 2020 | PAND | Pandion Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 18.00 | 361,111 | 6,499,998 | 1,770,023 |
Jul 22 2020 | PAND | Pandion Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 7,184,596 | 0 | 0 |
Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 2,271,796 | 0 | 2,271,796 |
Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 18.00 | 3,333,333 | 59,999,994 | 5,605,129 |
Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 8,405,656 | 0 | 0 |
Jul 10 2020 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 27.50 | 275,000 | 7,562,500 | 3,436,214 |
Jul 02 2020 | RYTM | RHYTHM PHARMACEUTICALS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 22.15 | 61,901 | 1,371,237 | 5,210,088 |
Jul 02 2020 | RYTM | RHYTHM PHARMACEUTICALS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 21.87 | 25,527 | 558,311 | 5,184,561 |
Jul 02 2020 | RYTM | RHYTHM PHARMACEUTICALS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 22.04 | 44,153 | 972,969 | 5,140,408 |
Jun 29 2020 | VSTM | Verastem, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 1.91 | 1,161,300 | 2,219,941 | 16,142,051 |
Jun 29 2020 | RYTM | RHYTHM PHARMACEUTICALS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 25.05 | 11,568 | 289,768 | 5,410,744 |
Jun 29 2020 | RYTM | RHYTHM PHARMACEUTICALS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 23.31 | 86,706 | 2,020,848 | 5,324,038 |
Jun 29 2020 | RYTM | RHYTHM PHARMACEUTICALS, I ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 22.19 | 52,049 | 1,154,999 | 5,271,989 |
Jun 24 2020 | FMTX | Forma Therapeutics Holdin ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 5,011,651 | 0 | 5,011,651 |
Jun 24 2020 | FMTX | Forma Therapeutics Holdin ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 20.00 | 4,000,000 | 80,000,000 | 9,011,651 |
Jun 24 2020 | FMTX | Forma Therapeutics Holdin ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 21,437,376 | 0 | 0 |
Jun 24 2020 | FMTX | Forma Therapeutics Holdin ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 5,011,651 | 0 | 5,011,651 |
Jun 24 2020 | FMTX | Forma Therapeutics Holdin ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 20.00 | 4,000,000 | 80,000,000 | 9,011,651 |
Jun 24 2020 | FMTX | Forma Therapeutics Holdin ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 21,437,376 | 0 | 0 |
Apr 03 2020 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Sell | 48.00 | 4,858,260 | 233,196,480 | 0 |
Mar 31 2020 | PHAT | Phathom Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 24.60 | 30,000 | 738,000 | 3,676,808 |
Mar 31 2020 | PHAT | Phathom Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 24.55 | 30,600 | 751,264 | 3,707,408 |
Mar 17 2020 | IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 0.00 | 829,348 | 0 | 829,348 |
Mar 17 2020 | IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | 16.00 | 625,000 | 10,000,000 | 1,454,348 |
Mar 17 2020 | IMRA | IMARA Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | 0.00 | 1,741,358 | 0 | 0 |
Mar 13 2020 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 7.89 | 6,337,135 | 49,999,995 | 10,874,613 |
Jan 24 2020 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 68.00 | 9,724,598 | 661,272,664 | 0 |
Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 16.00 | 1,500,000 | 24,000,000 | 1,500,000 |
Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 16.00 | 1,500,000 | 24,000,000 | 1,500,000 |
Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 1,661,214 | 0 | 3,161,214 |
Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 0.00 | 1,661,214 | 0 | 3,161,214 |
Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 10,327,777 | 0 | 0 |
Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | 0.00 | 10,327,777 | 0 | 0 |
Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 2,008,409 | 0 | 2,008,409 |
Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 1,340,116 | 0 | 3,348,525 |
Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 15.00 | 1,333,333 | 19,999,995 | 4,681,858 |
Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 2,008,409 | 0 | 0 |
Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 1,340,116 | 0 | 0 |
Jun 13 2019 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 19.88 | 15,000 | 298,200 | 15,000 |
Apr 15 2019 | SCPH | scPharmaceuticals Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 2.70 | 389,862 | 1,052,627 | 3,247,005 |
Jan 28 2019 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 38.00 | 263,158 | 10,000,004 | 7,775,207 |
Dec 14 2018 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 15.50 | 1,006,452 | 15,600,006 | 4,858,260 |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 0.00 | 1,525,235 | 0 | 1,525,235 |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 0.00 | 3,653,908 | 0 | 5,179,143 |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 11.00 | 4,545,455 | 50,000,005 | 9,724,598 |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Option Exercise | 0.00 | 2,443,794 | 0 | 0 |
Dec 13 2018 | THOR | Synthorx, Inc. | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Option Exercise | 0.00 | 5,854,439 | 0 | 0 |
Nov 01 2018 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 9.90 | 15,000 | 148,500 | 15,000 |
Nov 01 2018 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 9.90 | 15,000 | 148,500 | 15,000 |
Oct 05 2018 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 8.25 | 2,424,242 | 19,999,997 | 4,537,478 |
Oct 05 2018 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 8.25 | 2,424,242 | 19,999,997 | 4,537,478 |
Oct 03 2018 | ARVN | ARVINAS INC. | RA CAPITAL MANAGEMENT, LLC | Buy | 0.00 | 1,847,002 | 0 | 1,847,002 | |
Oct 03 2018 | ARVN | ARVINAS INC. | RA CAPITAL MANAGEMENT, LLC | Buy | 0.00 | 291,410 | 0 | 2,138,412 | |
Oct 03 2018 | ARVN | ARVINAS INC. | RA CAPITAL MANAGEMENT, LLC | Buy | 16.00 | 1,000,000 | 16,000,000 | 3,138,412 | |
Oct 03 2018 | ARVN | ARVINAS INC. | RA CAPITAL MANAGEMENT, LLC | Option Exercise | 0.00 | 6,002,761 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | RA CAPITAL MANAGEMENT, LLC | Option Exercise | 0.00 | 947,085 | 0 | 0 | |
Jul 02 2018 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 9.90 | 15,000 | 148,500 | 15,000 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 1,103,847 | 0 | 1,103,847 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 17.00 | 1,058,824 | 18,000,008 | 2,162,671 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 922,950 | 0 | 0 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 1,103,847 | 0 | 1,103,847 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 17.00 | 1,058,824 | 18,000,008 | 2,162,671 |
Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 922,950 | 0 | 0 |
Feb 16 2018 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 6.00 | 2,500,000 | 15,000,000 | 3,851,808 |
Dec 20 2017 | DRNA | Dicerna Pharmaceuticals I ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 0.00 | 2,645,442 | 0 | 5,074,013 |
Dec 20 2017 | DRNA | Dicerna Pharmaceuticals I ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Option Exercise | 0.00 | 76,500 | 0 | 0 |
Nov 15 2017 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 23.30 | 400,000 | 9,320,000 | 7,488,651 |
Nov 15 2017 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 24.00 | 23,398 | 561,550 | 7,512,049 |
Oct 16 2017 | KALV | KalVista Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 8.50 | 850,000 | 7,225,000 | 1,441,070 |
Sep 29 2017 | KALV | KalVista Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 6.71 | 6,000 | 40,260 | 6,000 |
Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 1,579,903 | 0 | 1,579,903 |
Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 15.00 | 533,333 | 7,999,995 | 2,113,236 |
Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 3,819,444 | 0 | 0 |
Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 4,409,170 | 0 | 0 |
Jun 22 2017 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 22.37 | 15,000 | 335,550 | 15,000 |
May 24 2017 | GTHX | G1 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Buy | 0.00 | 1,723,304 | 0 | 1,723,304 | |
May 24 2017 | GTHX | G1 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Buy | 0.00 | 560,940 | 0 | 2,284,244 | |
May 24 2017 | GTHX | G1 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Buy | 15.00 | 400,000 | 6,000,000 | 2,684,244 | |
May 24 2017 | GTHX | G1 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Option Exercise | 0.00 | 5,169,916 | 0 | 0 | |
May 24 2017 | GTHX | G1 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, LLC | Option Exercise | 0.00 | 1,682,822 | 0 | 0 | |
Apr 13 2017 | DRNA | Dicerna Pharmaceuticals I ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 3.19 | 76,500 | 244,035 | 76,500 |
Mar 27 2017 | CBYL | KalVista Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 7.88 | 12,000 | 94,560 | 12,000 |
Nov 23 2016 | CBYL | KalVista Pharmaceuticals, ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 591,070 | 0 | 591,070 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 616,646 | 0 | 616,646 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 573,624 | 0 | 1,190,270 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 13.00 | 161,538 | 2,099,994 | 1,351,808 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 4,316,531 | 0 | 0 |
Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 4,015,378 | 0 | 0 |
Sep 19 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 24.04 | 20,000 | 480,700 | 2,607,719 |
Sep 19 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 24.00 | 273,000 | 6,552,000 | 2,334,719 |
Sep 19 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 24.20 | 58,950 | 1,426,590 | 2,275,769 |
Sep 19 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 24.50 | 150,000 | 3,675,000 | 2,125,769 |
Sep 19 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 24.54 | 23,600 | 579,212 | 2,102,169 |
Feb 24 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 15.99 | 11,318 | 180,958 | 2,599,311 |
Feb 24 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 17.62 | 28,408 | 500,512 | 2,627,719 |
Jan 20 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 19.86 | 1,800 | 35,743 | 2,581,990 |
Jan 20 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 19.88 | 4,200 | 83,480 | 2,586,190 |
Jan 20 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 19.88 | 1,803 | 35,849 | 2,587,993 |
Jan 13 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 17.93 | 4,153 | 74,479 | 2,568,706 |
Jan 13 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 19.12 | 5,941 | 113,585 | 2,574,647 |
Jan 13 2016 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 19.97 | 5,543 | 110,674 | 2,580,190 |
Nov 18 2015 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 0.00 | 1,172,060 | 0 | 5,213,651 |
Nov 18 2015 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Buy | 16.00 | 1,875,000 | 30,000,000 | 7,088,651 |
Nov 18 2015 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 1,172,060 | 0 | 1,172,060 |
Nov 18 2015 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | 0.00 | 1,172,060 | 0 | 0 |
Oct 30 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.00 | 149,200 | 2,088,800 | 2,469,552 |
Oct 30 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.00 | 95,000 | 1,330,000 | 2,564,552 |
Oct 26 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.03 | 5,410 | 75,883 | 2,320,352 |
Oct 21 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.88 | 23,934 | 356,049 | 2,303,877 |
Oct 21 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.95 | 7,965 | 119,070 | 2,311,842 |
Oct 21 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.83 | 3,100 | 45,976 | 2,314,942 |
Oct 16 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 14.06 | 42,813 | 601,792 | 2,279,943 |
Oct 13 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 10.66 | 938,041 | 9,999,986 | 938,041 |
Oct 13 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 11.00 | 1,250,000 | 13,750,000 | 2,188,041 |
Oct 13 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 11.00 | 27,398 | 301,378 | 2,215,439 |
Oct 13 2015 | ACRS | Aclaris Therapeutics, Inc ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 11.00 | 21,691 | 238,555 | 2,237,130 |
Mar 28 2007 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | 1.40 | 300 | 420 | 3,713,962 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.40 | 12,684 | 17,758 | 3,750,578 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.35 | 24,630 | 33,251 | 3,725,948 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.36 | 2,200 | 2,992 | 3,723,748 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.37 | 1,250 | 1,713 | 3,722,498 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.41 | 2,900 | 4,089 | 3,719,598 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.42 | 2,040 | 2,897 | 3,717,558 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.43 | 400 | 572 | 3,717,158 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.44 | 1,700 | 2,448 | 3,715,458 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.45 | 1,050 | 1,523 | 3,714,408 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.47 | 900 | 1,323 | 3,713,508 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.50 | 15,442 | 23,163 | 3,698,066 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.51 | 100 | 151 | 3,697,966 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.52 | 900 | 1,368 | 3,697,066 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.53 | 100 | 153 | 3,696,966 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.54 | 9,204 | 14,174 | 3,687,762 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.55 | 20,400 | 31,620 | 3,667,362 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.56 | 3,100 | 4,836 | 3,664,262 |
Dec 29 2006 | LIPD | LIPID SCIENCES INC/ | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | 1.57 | 1,600 | 2,512 | 3,662,662 |